The Food and Drug Administration declined to approve MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, drugmaker Lykos Therapeutics said Friday. Experts and advocates ...

The Food and Drug Administration's decision to not approve a therapy using MDMA – also known as ecstasy and molly – to treat post-traumatic stress disorder means momentum for the use of psychedelics ...

The Food and Drug Administration (FDA) declined on Friday to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD). The agency has asked Lykos Therapeutics, ...

Veterans, members of Congress, and many others advocated for the groundbreaking PTSD treatment, but the FDA declined it saying more research is needed. By Joshua Skovlund Updated Aug 12, 2024 2:37 PM ...

WASHINGTON – MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the ...

We’re honored to welcome Bruce Sewick, LCPC, CADC, a nationally respected educator and clinician, for a powerful presentation on MDMA-assisted psychotherapy and its transformative potential for ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using ...

Entrepreneurs that had high hopes that MDMA would snag approval to treat post-traumatic stress disorder had their dreams dashed when the U.S. Food and Drug Administration rejected it as a treatment ...

The U.S. Food and Drug Administration (FDA) has decided not to approve a psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder (PTSD), according to Lykos Therapeutics, ...